Skip to Main Content

Cocrystal Pharma, Inc. Common Stock

COCP Real Time Price USD
N/A
N/A
N/A
...
...
Overview
Financials
Forecast
Insiders
Institutions
Government
Ownership
Income
Balance Sheet
Cash Flow
Revenue Breakdown

Recent trades of COCP by members of U.S. Congress

Quiver Logo

No Congress Trading data for this ticker

Congress Trading Dashboard
COCP Stock Insider Trading Activity
Name
Type
Shares
Price
Shares Held
Date
Reported
COCP Stock Institutional Owners
Investor
Shares
Change in Shares
Market Value
Date
Reported
COCP Derivatives Institutional Owners
Investor
Type
Shares
Change in Shares
Market Value
Date
Reported

Recently reported changes by institutional investors

Quarterly net insider trading by COCP's directors and management

Quiver Logo

No recent Insider Trading for this ticker

Insider Trading Dashboard

Government lobbying spending instances

Quiver Logo

No Corporate Lobbying instances for this ticker

Corporate Lobbying Dashboard

Estimated quarterly lobbying spending

Quiver Logo

No Corporate Lobbying data for this ticker

Corporate Lobbying Dashboard

COCP Revenue by Segment or Geography

By Segment
By Geography
Quiver Logo

No Revenue by Segment data for this ticker

Revenue Breakdown Dashboard
Quiver Logo

No Revenue by Geography data for this ticker

Revenue Breakdown Dashboard
COCP Income Statement
COCP Balance Sheet
COCP Cash Flow
U.S. Patents

New patents grants

  • Patent Title: Combinations of inhibitors of influenza virus replication Feb. 25, 2025
  • Patent Title: Formulations of influenza therapeutics Dec. 03, 2024
  • Patent Title: Pyridopyrazine and pyridotriazine inhibitors of influenza virus replication Jul. 16, 2024
  • Patent Title: Combination therapy for treatment of hcv Sep. 12, 2023
  • Patent Title: Pyrrolopyrimidine derivatives useful as inhibitors of influenza virus replication May. 25, 2021
  • Patent Title: Inhibitors of hepatitis c virus polymerase Mar. 16, 2021
  • Patent Title: Inhibitors of hepatitis c virus polymerase Nov. 05, 2019
  • Patent Title: Inhibitors of hepatitis c virus polymerase Oct. 01, 2019
  • Patent Title: Nucleoside analogs for treatment of the flaviviridae family of viruses and cancer Jul. 03, 2018
  • Patent Title: Potent and selective inhibitors of hepatitis c virus Apr. 03, 2018
  • Patent Title: Potent and selective inhibitors of hepatitis c virus Mar. 27, 2018
  • Patent Title: Potent and selective inhibitors of hepatitis c virus Nov. 10, 2015
  • Patent Title: Purine nucleoside monophosphate prodrugs for treatment of cancer and viral infections Nov. 03, 2015
  • Patent Title: Hcv ns3 protease inhibitors May. 26, 2015
Government Contracts

Federal grants, loans, and purchases

Quiver Logo

No Government Contracts for this ticker

Government Contracts Dashboard
Government Contracts

Estimated quarterly amount awarded from public contracts

Quiver Logo

No recent Government Contracts for this ticker

Government Contracts Dashboard
COCP News

Recent insights relating to COCP

WallStreetBets

Number of mentions of COCP in WallStreetBets Daily Discussion

CNBC Recommendations

Recent picks made for COCP stock on CNBC

Top ETF Holders

ETFs with the largest estimated holdings in COCP

COCP Analyst Ratings

COCP Stock Forecasts
...

  • ... Highest Price Target
  • ... Median Price Target
  • ... Lowest Price Target
COCP Analyst Forecasts
Analyst
Firm
Current
Previous
Date
Frequently Asked Questions
  • Is $COCP stock a Buy, Sell, or Hold?

  • What is the price target for $COCP stock?

* Analyst consensus is not financial advice. Please see our data disclaimers .

COCP Top Shareholders
Shareholder
Shares Held
COCP Options Owners
Shareholder
Security
Underlying Shares
Frequently Asked Questions
  • Who owns $COCP stock?

  • Who owns the most shares of $COCP stock?

  • What funds own $COCP stock?

* These are estimates based on data taken from SEC filings. There may be inaccuracies due to parsing errors, accidental double-counting, incorrect classification of indirectly owned shares, or any other number of issues.

COCP Stock Smart Score

The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.

The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.
?

Sign Up to view COCP Smart Score

Score Breakdown
Bull Case vs Bear Case

See concise summaries of analyst reports, presenting both bullish and bearish arguments for a stock.

Example:

Bulls Say:

The Bulls Say summary highlights positive aspects of the stock.

Bears Say:

The Bears Say summary points out potential risks and negative aspects of the stock.

Show More
Back To Top